It all started with a meeting in a hotel close to Bangalore airport in 2013, meeting Rajat and Rakesh, co-founders of Sankalp India Foundation, was a game changer for all of us. Since than we have launched two BMT centers: One at the People Tree Hospital in Bangalore in 2015 and one at CIMS Hospital in Ahmedabad in 2017. As of December 2019 a total of 260 BMTs have been performed 245 of which for thalassemia. Overall cure rates are over 85% with a mortality of 5% including 22 haploidentical transplants (from partially compatible parents). In matched-related, generally from siblings, transplants, since 2018, cure rates have gone up to 90% and mortality fallen to 4%. In these centers BMT is offered for a non-profit rate of 12.500 USD for matched-related and 19.000 USD for partially matched related transplantation. This cost may be further reduced thanks to a contribution by DKMS-Germany. Many of the achievements of Cure2Children and partners, in particular Sankalp India Foundation, would not have been possible without the support of DKMS, one of the largest stem cell donor registries worldwide. In fact, to date, DKMS has performed over 12.000 compatibility tests (HLA typing) free-of-cost from buccal swab DNA which is simple enough that it can be done anywhere in the world.
Sankalp India Foundation also manages several thalassemia day care centers throughout India managing over 2.000 patients.